Replies to post #285486 on Anavex Life Sciences Corp (AVXL)

[JWC3]

So that’s your opinion. Mine is:


Yes your comment is just that.... absurd to max( no logic & no reason & only blank BS). What to expect is a sea change in ANAVEX. It will probably get absolute approval for A 2-73 with 18+yo girls with Rett Syndrome from the FDA a short term after it reads out RTT due to accelerated processing already granted by the FDA! A portion of the Rett Syndrome patient population, my guess is 30%. This will start a chain reaction that will quickly yield provisional approval in Australia for A 2-73 for Dementia and Rett Syndrome. After a 3 month ramp up in Australia this will naturally expand to ROW. Quickly, revenues reach into the Billions of $. Stock price will follow revenue. Skeptics will lose interest and short interest will reach new lows.